Meyer Heyman

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program

Journal of Clinical Oncology · 1998 · 2,302 citations

Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature

Review · Cancer · 2007 · 181 citations